Ameriabank has entered into long-term subordinated loan agreement with Symbiotics SA for USD 15 million, with possible increase of up to USD 25 million. The funds qualify as Bank Tier 2 capital instrument under Basel III framework and are aimed at strengthening the overall capital position of the Bank.

Ameriabank announces 2020 Q3 unaudited financial results

Ameriabank announces 2020 Q2 unaudited financial results

Ameriabank announces 2020 Q1 unaudited financial results

S&P Global Ratings re-affirms Ameriabank’s (the Bank) 'B+/B' long and short-term issuer credit ratings with stable outlook.